NasdaqCM - Delayed Quote USD

Jin Medical International Ltd. (ZJYL)

3.0400 +0.0100 (+0.33%)
At close: August 21 at 4:00:00 PM EDT
3.0100 -0.0300 (-0.99%)
After hours: August 21 at 7:39:08 PM EDT
Chart Range Bar
Loading chart for ZJYL
  • Previous Close 3.0300
  • Open 3.1000
  • Bid 2.8700 x 100
  • Ask 3.5000 x 100
  • Day's Range 3.0397 - 3.1828
  • 52 Week Range 1.5300 - 17.1800
  • Volume 39,526
  • Avg. Volume 976,472
  • Market Cap (intraday) 226.977M
  • Beta (5Y Monthly) 7.34
  • PE Ratio (TTM) 15.20
  • EPS (TTM) 0.2000
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.

www.zhjmedical.com

273

Full Time Employees

September 30

Fiscal Year Ends

Performance Overview

Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZJYL
30.91%
S&P 500 (^GSPC)
12.11%

1-Year Return

ZJYL
73.38%
S&P 500 (^GSPC)
20.47%

3-Year Return

ZJYL
78.73%
S&P 500 (^GSPC)
74.43%

5-Year Return

ZJYL
62.00%
S&P 500 (^GSPC)
72.78%

Statistics

View More

Valuation Measures

Annual
As of 8/20/2026
  • Market Cap

    226.23M

  • Enterprise Value

    217.03M

  • Trailing P/E

    15.65

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.24

  • Price/Book (mrq)

    7.60

  • Enterprise Value/Revenue

    11.38

  • Enterprise Value/EBITDA

    307.81

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.95%

  • Return on Assets (ttm)

    0.50%

  • Return on Equity (ttm)

    4.02%

  • Revenue (ttm)

    19.73M

  • Net Income Avi to Common (ttm)

    1.17M

  • Diluted EPS (ttm)

    0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.1M

  • Total Debt/Equity (mrq)

    69.34%

  • Levered Free Cash Flow (ttm)

    -7.49M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.0400 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch